Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Med Sci Monit ; 28: e936367, 2022 Jun 02.
Artigo em Inglês | MEDLINE | ID: mdl-35651299

RESUMO

BACKGROUND Perioperative hemodynamic instability mediated by anaphylaxis is a life-threatening complication in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). This study aimed to evaluate the effect of clemastine fumarate in this specific patient population. MATERIAL AND METHODS We enrolled 100 participants who met the inclusion criteria and randomly allocated them to the treatment group and the placebo group. Participants in the treatment group and the placebo group were treated separately with an injection of clemastine fumarate and saline, respectively. Plasma histamine concentration and blood pressure were quantified at 5 timepoints during the perioperative period, and differences between the 2 groups were assessed by repeated-measures ANOVA. The postoperative complications and in-hospital mortality also were evaluated. All participants were followed up for 7 days after cardiac surgery. RESULTS Plasma histamine concentrations increased in both groups but were statistically significantly lower in the treatment group during the perioperative period (P=0.007). Diastolic blood pressure (P=0.014) and mean arterial pressure (P=0.024) in the treatment group were significantly higher than in the placebo group during the perioperative period. The coefficients of variation for systolic (13.9±4.2% vs 17.2±4.4%, P<0.01) and diastolic (12.9±4.9% vs 15.3±5.2%, P=0.02) blood pressure were significantly lower in the treatment group compared with the placebo group. CONCLUSIONS Pretreatment with clemastine fumarate restrains the increase in histamine concentration and provides safer hemodynamics in patients undergoing cardiac surgery with CPB.


Assuntos
Clemastina , Hemodinâmica , Doenças Vasculares , Anafilaxia , Ponte Cardiopulmonar , Clemastina/efeitos adversos , Clemastina/farmacologia , Hemodinâmica/efeitos dos fármacos , Histamina , Humanos , Assistência Perioperatória , Doenças Vasculares/tratamento farmacológico
2.
Cesk Patol ; 18(4): 244-52, 1982 Nov.
Artigo em Tcheco | MEDLINE | ID: mdl-6129069

RESUMO

Selective necrosis of rat testicles is known to be produced by cadmium in subtoxic doses due to impairment of vessel structures. Classical antihistaminics in the same time in order to exclude that the lesion might have been produced by local release of histamine. Antihistaminics did not prevent necrosis. Instead, Clemastine stressed an interstitial testicular haemorrhage a bit. Methyldosulepine administered with calcium could decrease the vascular permeability because haemorrhage was almost lacking. The finding supports an idea of possible interaction between calcium and cadmium ions.


Assuntos
Cádmio/efeitos adversos , Clemastina/efeitos adversos , Dibenzotiepinas/efeitos adversos , Dotiepina/efeitos adversos , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Pirrolidinas/efeitos adversos , Doenças Testiculares/patologia , Animais , Dotiepina/análogos & derivados , Masculino , Necrose , Ratos , Açúcares Ácidos/efeitos adversos , Doenças Testiculares/induzido quimicamente , Testículo/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA